Abstract
A new variant translocation, (8;20)(q22;q13) in a patient with acute myelocytic leukemia (AML) M2 is reported. As far as we know, this is the second case of the t(8;20) in de novo AML. Further studies are required to clarify the key event leading to the development of AML-M2.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
